Recurrent Transcriptomic Organization Across Sample Groups in Pediatric Neuroblastoma: A Prospectively Constrained Single-Cell Analysis

Neuroblastoma exhibits substantial transcriptional heterogeneity and developmental-state organization. This study evaluated whether a recurrent transcriptomic pattern could be identified across source-defined Tumour cluster 1 (TC1) groups in an independently derived pediatric neuroblastoma single-cell dataset under prospectively specified analytical constraints. Three TC1 SampleName groups met the prespecified quantitative eligibility criterion. Recurrent expression required concordant median-expression direction across all three eligible TC1 comparisons against within-sample Leukocytes. A total of 569 genes met this criterion, comprising 505 recurrent higher-expression and 64 recurrent lower-expression genes. Functional enrichment of the complete recurrent gene sets identified organized representation across mitochondrial-energy/respiration, metabolism, cell-cycle/proliferation, translation and protein processing, neural/neurodevelopmental, cytoskeletal, immune/antigen-presentation, and additional functional categories. The findings demonstrate reproducible-within-dataset TC1 transcriptomic organization across three eligible SampleName groups but do not establish patient-level replication, causal mechanism, clinical relevance, or tissue-level architectural control. The available measurements did not directly evaluate the frozen BOCM relationships or candidate convergence points; therefore, BOCM-H01 remains NOT_EVALUABLE_FROM_GOSH_ALONE. The study is presented as a bounded independent pediatric transcriptomic challenge and characterization rather than direct validation or falsification of BOCM.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-25
DOI
https://doi.org/10.5281/zenodo.22965310
Primary Topic
Neuroblastoma Research and Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
preprint

Recurrent Transcriptomic Organization Across Sample Groups in Pediatric Neuroblastoma: A Prospectively Constrained Single-Cell Analysis

Wayne Squires
Zenodo (CERN European Organization for Nuclear Research)
Neuroblastoma Research and Treatments
preprint

Recurrent Transcriptomic Organization Across Sample Groups in Pediatric Neuroblastoma: A Prospectively Constrained Single-Cell Analysis

Wayne Squires
preprint en

Abstract

Neuroblastoma exhibits substantial transcriptional heterogeneity and developmental-state organization. This study evaluated whether a recurrent transcriptomic pattern could be identified across source-defined Tumour cluster 1 (TC1) groups in an independently derived pediatric neuroblastoma single-cell dataset under prospectively specified analytical constraints. Three TC1 SampleName groups met the prespecified quantitative eligibility criterion. Recurrent expression required concordant median-expression direction across all three eligible TC1 comparisons against within-sample Leukocytes. A total of 569 genes met this criterion, comprising 505 recurrent higher-expression and 64 recurrent lower-expression genes. Functional enrichment of the complete recurrent gene sets identified organized representation across mitochondrial-energy/respiration, metabolism, cell-cycle/proliferation, translation and protein processing, neural/neurodevelopmental, cytoskeletal, immune/antigen-presentation, and additional functional categories. The findings demonstrate reproducible-within-dataset TC1 transcriptomic organization across three eligible SampleName groups but do not establish patient-level replication, causal mechanism, clinical relevance, or tissue-level architectural control. The available measurements did not directly evaluate the frozen BOCM relationships or candidate convergence points; therefore, BOCM-H01 remains NOT_EVALUABLE_FROM_GOSH_ALONE. The study is presented as a bounded independent pediatric transcriptomic challenge and characterization rather than direct validation or falsification of BOCM.

Zenodo (CERN European Organization for Nuclear Research)
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recurrent Transcriptomic Organization Across Sample Groups in Pediatric Neuroblastoma: A Prospectively Constrained Single-Cell Analysis — Wayne Squires · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS